A 30-year-old medical puzzle leads researchers to develop a new molecular therapy.
Using left-handed DNA to better monitor and control PCR.
Han van Krieken
Advances in genomics are thrilling, but a tumor is more than a bundle of genetic information
CRISPR is the new kid on the block, but do ZFNs and TALENs still have a place?
Jef Boeke, Professor, Department of Biochemistry and Molecular Pharmacology at NYU
Stephen J. Haggarty
COMET could allow precise spatiotemporal targeting of disease-controlling mechanisms
Retrotransposons can initiate oncogenesis, with an increased risk in certain populations
An ambitious, large-scale project plans to fully construct a synthetic human genome
The discovery of multiple sclerosis' genetic origin may lead to better therapies
New software couples computer programming with cell function using the ultimate coding language: DNA
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.